PLATINUM BUTE IV INJECTION

Ország: Ausztrália

Nyelv: angol

Forrás: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktív összetevők:

PHENYLBUTAZONE SODIUM; SODIUM SALICYLATE

Beszerezhető a:

RANDLAB AUSTRALIA PTY LTD

INN (nemzetközi neve):

phenylbutazone sodium(200mg/mL)+sodium salicylate(50mg/mL)

Gyógyszerészeti forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Összetétel:

PHENYLBUTAZONE SODIUM ANALGESIC Active 200.0 mg/ml; SODIUM SALICYLATE PHENOL Active 50.0 mg/ml

db csomag:

100mL

Osztály:

VM - Veterinary Medicine

Gyártó:

RANDLAB AUSTRALIA

Terápiás terület:

MUSCULOSKELETAL SYSTEM

Termék összefoglaló:

Poison schedule: 4; Withholding period: MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED in horses intended for human consumption.; Host/pest details: HORSE: [MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [MUSCULOSKELETAL CONDITIONS]; For the relief of painful musculoskeletal conditions in horses.DO NOT use in horses intended for human consumption. NOT for use in horses with serious cardiac, hepatic or renal dysfunction, history of blood disorders (especially haemoglobinuria) or gastro-intestinal disturbances.

Engedélyezési státusz:

Registered

Engedély dátuma:

2023-07-01

Betegtájékoztató

•
•
Bottle main
panel
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Platinum
Bute
IV Injection
ACTIVE CONSTITUENTS: 200
mg/mL
PHENYLSUTAZONE SODIUM
.
(equivalent
to
186
mg/mL
PHENYLBUTAZONE base)
50
mg/mL
SODIUM SALICYLATE
For the relief of painful musculoskeletal conditions
in
horses.
READ THE OUTER CARTON BEFORE USING THIS PRODUCT
100
ml
+
RLP
Approved
Platinum Bute IV Injection label
68303/58052 100 mL bottle and carton
page 1
of
5
Version RLP 29/05/2014
Bottle ancillary
panel
Non-steroidal, anti-inflammatory, analgesic
&
antipyretic.
For use
in
treatment of musculoskeletal disorders.
DIRECTIONS FOR USE
RESTRAINT:
DO
NOT
USE in
horses
intended
for
human
consumption.
Contraindications:
This
product
is contraindicated
for
use in horses with
serious
cardiac, hepatic
or
renal
dysfunction,
history
of
blood disorders (especially haemoglobinuria)
or
gastro-intestinal
disturbances.
Dosage and Administration
Admin'ister
by
SLOW INTRAVENOUS INJECTION at room temperature.
HORSES
Initially 5-10
mL
per 225
kg
per day.
and
Subsequent doses, depending on response, may be reduced
to
2.5-5
mL
per
FOALS
225
kg
per day.
Treatment should
be
continued for 5-6 days.
MEAT WITHHOLDING PERIOD:
NOT TO
BE
USED in horses intended
for
human consumption.
FIRST AID: If poisoning occurs, contact a
doctor
or Poisons Information Centre. Phone
Australia 131126.
DISPOSAL: Dispose of empty container and outer packaging
by
wrapping with paper and
putting
in
garbage.
STORAGE:
Store between 2 and
soc
(Refrigerate.
Do
not freeze). Protect from light. Store vials
in
an
upright position.
·
Following withdrawal of the first dose, use the remainder of the vial
within 4 days or discard the
unused portion.
APVMA Approval
No.
68303/58052
Registered to:
RAND
LAB
AUSTRALIA PTY LTD
ACN 114 948 637
7/85 Alfred Road,
Chipping Norton NSW 2170 Australia
Phone: [phone]
Fax:
(61-2) 9728 4352
Email: [e-mail]
Batch
No.
Expiry
Platinum Bute IV Injection label
68303/58052 100
mL
bottle
and
carton
page 2 of 5

Termékjellemzők

PRODUCT NAME: PLATINUM BUTE IV
PAGE: 1 OF 5
This revision issued: July, 2014
SAFETY DATA SHEET
Issued by: Randlab Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
RANDLAB AUSTRALIA PTY LTD
PHONE: [phone]
7/85 ALFRED RD
FAX: [phone]
CHIPPING NORTON, NSW 2170, AUSTRALIA
CHEMICAL NATURE:
Water solution of Phenylbutazone.
TRADE NAME:
PLATINUM BUTE IV
PRODUCT USE:
For the relief of painful musculoskeletal conditions in horses.
CREATION DATE:
DECEMBER, 2010
THIS VERSION ISSUED:
JULY, 2014
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S25. Avoid contact with eyes.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P262: Do not get in eyes, on skin, or on clothing.
RESPONSE
P337: If eye irritation persists: seek medical attention.
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P410: Protect from sunlight.
P411: Store at temperatures not exceeding 30°C.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping
with paper and putting in garbage. For
larger quantities, if recycling or reclaiming is not possible, use a
commercial waste disposal service
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, pale yellow liquid with no sedimentation.
ODOUR:
Distinctive odour of chlorocresol.
MAJOR HEALTH HAZARDS:
no significant risk factors have been fou